Achaogen

AKAOQ OTCMKTS
0.0101
+0.0001
+1.00%
Opening 09:47 08/21 EDT
Open
0.0080
Prev Close
0.0100
High
0.0101
Low
0.0080
Volume
4.42K
Avg Vol (3M)
3.89M
52 Week High
5.55
52 Week Low
0.0060
% Turnover
0.01%
Market Cap
645.19K
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Achaogen AKAOQ stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Achaogen, Inc. is a late-stage biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of antibacterial treatments against multi-drug resistant (MDR) gram-negative infections. The Company is involved in researching and developing plazomicin, its lead product candidate, for the treatment of serious bacterial infections, including complicated urinary tract infection (cUTI), blood stream infections and other infections due to MDR Enterobacteriaceae, including carbapenem-resistant Enterobacteriaceae (CRE). Plazomicin is an intravenous aminoglycoside antibiotic. The Company has developed plazomicin by chemically modifying sisomicin, a naturally occurring aminoglycoside, in order to overcome common aminoglycoside resistance mechanisms. The Company has a portfolio of small molecule and antibody programs. The Company's Early Development programs include C-Scape and LpxC.
MORE >

Recently

Name
Price
%Change